List of Tables

Table 1. Peptide Therapy Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Peptide Therapy Market Restraints

Table 3. Peptide Therapy Market Trends

Table 4. Peptide Therapy Industry Policy

Table 5. Global Peptide Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Peptide Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Peptide Therapy Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Peptide Therapy Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Peptide Therapy Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Peptide Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Peptide Therapy Mergers & Acquisitions, Expansion Plans

Table 12. Global Peptide Therapy Manufacturers Product Type

Table 13. Head Office and Peptide Therapy Production Site of Key Manufacturer

Table 14. Peptide Therapy Capacity of Major Manufacturers and Future Plan

Table 15. China Peptide Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Peptide Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Peptide Therapy Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Peptide Therapy Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Peptide Therapy Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Peptide Therapy Production by Region, 2020-2025, (K Units)

Table 21. Global Peptide Therapy Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Peptide Therapy Upstream (Raw Materials)

Table 23. Global Peptide Therapy Typical Customers

Table 24. Peptide Therapy Typical Distributors

Table 25. by Type, Global Peptide Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Peptide Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Peptide Therapy Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Peptide Therapy Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Peptide Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Peptide Therapy Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Peptide Therapy Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Peptide Therapy Sales Quantity Market Share, 2020-2031

Table 35. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 36. Eli Lilly Peptide Therapy Models, Specifications, and Application

Table 37. Eli Lilly Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Eli Lilly Company Profile and Main Business

Table 39. Eli Lilly Recent Developments

Table 40. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 41. AstraZeneca Peptide Therapy Models, Specifications, and Application

Table 42. AstraZeneca Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. AstraZeneca Company Profile and Main Business

Table 44. AstraZeneca Recent Developments

Table 45. Merck Company Information, Head Office, Market Area, and Industry Position

Table 46. Merck Peptide Therapy Models, Specifications, and Application

Table 47. Merck Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Merck Company Profile and Main Business

Table 49. Merck Recent Developments

Table 50. Ipsen Company Information, Head Office, Market Area, and Industry Position

Table 51. Ipsen Peptide Therapy Models, Specifications, and Application

Table 52. Ipsen Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Ipsen Company Profile and Main Business

Table 54. Ipsen Recent Developments

Table 55. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position

Table 56. Novo Nordisk Peptide Therapy Models, Specifications, and Application

Table 57. Novo Nordisk Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Novo Nordisk Company Profile and Main Business

Table 59. Novo Nordisk Recent Developments

Table 60. Teva Pharmaceutical Industries Company Information, Head Office, Market Area, and Industry Position

Table 61. Teva Pharmaceutical Industries Peptide Therapy Models, Specifications, and Application

Table 62. Teva Pharmaceutical Industries Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Teva Pharmaceutical Industries Company Profile and Main Business

Table 64. Teva Pharmaceutical Industries Recent Developments

Table 65. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 66. Abbott Laboratories Peptide Therapy Models, Specifications, and Application

Table 67. Abbott Laboratories Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Abbott Laboratories Company Profile and Main Business

Table 69. Abbott Laboratories Recent Developments

Table 70. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 71. Sanofi Peptide Therapy Models, Specifications, and Application

Table 72. Sanofi Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Sanofi Company Profile and Main Business

Table 74. Sanofi Recent Developments

Table 75. J & J Company Information, Head Office, Market Area, and Industry Position

Table 76. J & J Peptide Therapy Models, Specifications, and Application

Table 77. J & J Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. J & J Company Profile and Main Business

Table 79. J & J Recent Developments

Table 80. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 81. Novartis Peptide Therapy Models, Specifications, and Application

Table 82. Novartis Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Novartis Company Profile and Main Business

Table 84. Novartis Recent Developments

Table 85. Takeda Company Information, Head Office, Market Area, and Industry Position

Table 86. Takeda Peptide Therapy Models, Specifications, and Application

Table 87. Takeda Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Takeda Company Profile and Main Business

Table 89. Takeda Recent Developments

Table 90. Ferring Company Information, Head Office, Market Area, and Industry Position

Table 91. Ferring Peptide Therapy Models, Specifications, and Application

Table 92. Ferring Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Ferring Company Profile and Main Business

Table 94. Ferring Recent Developments

Table 95. AbbVie Company Information, Head Office, Market Area, and Industry Position

Table 96. AbbVie Peptide Therapy Models, Specifications, and Application

Table 97. AbbVie Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. AbbVie Company Profile and Main Business

Table 99. AbbVie Recent Developments

Table 100. Heinis Company Information, Head Office, Market Area, and Industry Position

Table 101. Heinis Peptide Therapy Models, Specifications, and Application

Table 102. Heinis Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 103. Heinis Company Profile and Main Business

Table 104. Heinis Recent Developments

Table 105. Hemmo Company Information, Head Office, Market Area, and Industry Position

Table 106. Hemmo Peptide Therapy Models, Specifications, and Application

Table 107. Hemmo Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 108. Hemmo Company Profile and Main Business

Table 109. Hemmo Recent Developments

Table 110. Emcure Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 111. Emcure Pharmaceutical Peptide Therapy Models, Specifications, and Application

Table 112. Emcure Pharmaceutical Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 113. Emcure Pharmaceutical Company Profile and Main Business

Table 114. Emcure Pharmaceutical Recent Developments

Table 115. Cipla Company Information, Head Office, Market Area, and Industry Position

Table 116. Cipla Peptide Therapy Models, Specifications, and Application

Table 117. Cipla Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 118. Cipla Company Profile and Main Business

Table 119. Cipla Recent Developments

Table 120. Gland Pharma Company Information, Head Office, Market Area, and Industry Position

Table 121. Gland Pharma Peptide Therapy Models, Specifications, and Application

Table 122. Gland Pharma Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 123. Gland Pharma Company Profile and Main Business

Table 124. Gland Pharma Recent Developments

Table 125. Troikaa Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 126. Troikaa Pharmaceuticals Peptide Therapy Models, Specifications, and Application

Table 127. Troikaa Pharmaceuticals Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 128. Troikaa Pharmaceuticals Company Profile and Main Business

Table 129. Troikaa Pharmaceuticals Recent Developments

Table 130. Biological E Company Information, Head Office, Market Area, and Industry Position

Table 131. Biological E Peptide Therapy Models, Specifications, and Application

Table 132. Biological E Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 133. Biological E Company Profile and Main Business

Table 134. Biological E Recent Developments

List of Figures

Figure 1. Peptide Therapy Picture

Figure 2. Global Peptide Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Peptide Therapy Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Peptide Therapy Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Peptide Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Peptide Therapy Sales Quantity (K Units) & (2020-2031)

Figure 7. China Peptide Therapy Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Peptide Therapy Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Peptide Therapy Market Share of Global, 2020-2031

Figure 10. Global Peptide Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Peptide Therapy Key Participants, Market Share, 2024

Figure 12. Global Peptide Therapy Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Peptide Therapy Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Peptide Therapy Production Market Share & Forecast by Region, 2020-2031

Figure 15. Peptide Therapy Industry Chain

Figure 16. Peptide Therapy Procurement Model

Figure 17. Peptide Therapy Sales Model

Figure 18. Peptide Therapy Sales Channels, Direct Sales, and Distribution

Figure 19. Parenteral Route of Administration

Figure 20. Mucosal Route of Administration

Figure 21. Oral Route of Administration

Figure 22. Transdermal Route of Administration

Figure 23. by Type, Global Peptide Therapy Consumption Value, 2020-2031, US$ Million

Figure 24. by Type, Global Peptide Therapy Consumption Value Market Share, 2020-2031

Figure 25. by Type, Global Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 26. by Type, Global Peptide Therapy Sales Quantity Market Share, 2020-2031

Figure 27. by Type, Global Peptide Therapy Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 28. Cancer

Figure 29. Cardiovascular Diseases

Figure 30. Gastrointestinal Disorders

Figure 31. Metabolic Disorders

Figure 32. Others

Figure 33. by Application, Global Peptide Therapy Consumption Value, 2020-2031, US$ Million

Figure 34. by Application, Global Peptide Therapy Revenue Market Share, 2020-2031

Figure 35. by Application, Global Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 36. by Application, Global Peptide Therapy Sales Quantity Market Share, 2020-2031

Figure 37. by Application, Global Peptide Therapy Price, 2020-2031, (US$/Unit)

Figure 38. By Region, Global Peptide Therapy Consumption Value Market Share, 2020-2031

Figure 39. By Region, Global Peptide Therapy Sales Quantity Market Share, 2020-2031

Figure 40. North America Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country, North America Peptide Therapy Consumption Value Market Share, 2024

Figure 42. Europe Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, Europe Peptide Therapy Consumption Value Market Share, 2024

Figure 44. Asia Pacific Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. By Country/Region, Asia Pacific Peptide Therapy Consumption Value Market Share, 2024

Figure 46. South America Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 47. By Country, South America Peptide Therapy Consumption Value Market Share, 2024

Figure 48. Middle East & Africa Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 49. United States Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 50. by Type, United States Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, United States Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 52. Europe Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 53. by Type, Europe Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, Europe Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 55. China Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 56. by Type, China Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, China Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 58. Japan Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 59. by Type, Japan Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, Japan Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 61. South Korea Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 62. by Type, South Korea Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, South Korea Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 64. Southeast Asia Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 65. by Type, Southeast Asia Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, Southeast Asia Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 67. India Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 68. by Type, India Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, India Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 70. Middle East & Africa Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 71. by Type, Middle East & Africa Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 72. by Application, Middle East & Africa Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 73. Research Methodology

Figure 74. Breakdown of Primary Interviews

Figure 75. Bottom-up Approaches

Figure 76. Top-down Approaches